Actively Recruiting

Phase Not Applicable
All Genders
NCT06053671

Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)

Led by King's College Hospital NHS Trust · Updated on 2024-10-23

60

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

Sponsors

K

King's College Hospital NHS Trust

Lead Sponsor

K

King's College London

Collaborating Sponsor

AI-Summary

What this Trial Is About

Focal cortical dysplasia (FCD) is a malformation of brain development, the most common cause of drug-resistant epilepsy and often caused by mutations in mammalian target of rapamycin (mTOR) pathway genes. Patients with FCD develop drug-resistant seizures. This study will look at FCD tissue removed during epilepsy surgery and aims to detect mutations in mTOR pathway genes in brain cells. Secondly, the investigators will establish if evidence of mutations found in brain cells can also be detected as circulating free DNA (cfDNA) in blood. By looking at which genes are made into proteins in individual cells found in epilepsy surgical tissue (single cell expression profiling),the investigators will attempt to identify new genetic targets in FCD. The main outcome will be finding new causes of epilepsy with FCD and the development of new diagnostic and screening tools.

CONDITIONS

Official Title

Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult and pediatric patients (male and female)
  • Histologically proven or suspected diagnosis of focal cortical dysplasia type IIA/B based on MRI, EEG, and PET
  • Awaiting resective epilepsy surgery
  • Able to attend hospital appointments and undergo blood and nasal swab sampling
  • Informed consent available
Not Eligible

You will not qualify if you...

  • Presence of any acute or chronic conditions that limit ability to participate
  • Refusal to give informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

King's College Hospital

London, United Kingdom

Actively Recruiting

Loading map...

Research Team

L

Laura Mantoan Ritter, MD PhD

CONTACT

S

Sylvini Lalnunhlimi

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here